
Targeting GI Drug Delivery with GlycoCaging Could Improve IBD Treatments
Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal (GI) tract. The drug delivery system, GlycoCaging, is …